Finch Therapeutics Group Inc (FNCH)
11.95
-0.20
(-1.65%)
USD |
OTCM |
Nov 04, 16:00
Finch Therapeutics Group Price to Book Value: 1.350 for Nov. 4, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 1.350 |
| November 01, 2024 | 1.372 |
| October 31, 2024 | 1.355 |
| October 30, 2024 | 1.344 |
| October 29, 2024 | 1.299 |
| October 28, 2024 | 1.327 |
| October 25, 2024 | 1.350 |
| October 24, 2024 | 1.355 |
| October 23, 2024 | 1.355 |
| October 22, 2024 | 1.372 |
| October 21, 2024 | 1.387 |
| October 18, 2024 | 1.361 |
| October 17, 2024 | 1.361 |
| October 16, 2024 | 1.361 |
| October 15, 2024 | 1.355 |
| October 14, 2024 | 1.316 |
| October 11, 2024 | 1.299 |
| October 10, 2024 | 1.299 |
| October 09, 2024 | 1.299 |
| October 08, 2024 | 1.299 |
| October 07, 2024 | 1.299 |
| October 04, 2024 | 1.320 |
| October 03, 2024 | 1.333 |
| October 02, 2024 | 1.344 |
| October 01, 2024 | 1.299 |
| Date | Value |
|---|---|
| September 30, 2024 | 1.352 |
| September 27, 2024 | 1.299 |
| September 26, 2024 | 1.242 |
| September 25, 2024 | 1.242 |
| September 24, 2024 | 1.242 |
| September 23, 2024 | 1.252 |
| September 20, 2024 | 1.287 |
| September 19, 2024 | 1.316 |
| September 18, 2024 | 1.294 |
| September 17, 2024 | 1.299 |
| September 16, 2024 | 1.299 |
| September 13, 2024 | 1.276 |
| September 12, 2024 | 1.317 |
| September 11, 2024 | 1.327 |
| September 10, 2024 | 1.363 |
| September 09, 2024 | 1.416 |
| September 06, 2024 | 1.416 |
| September 05, 2024 | 1.485 |
| September 04, 2024 | 1.493 |
| September 03, 2024 | 1.448 |
| August 30, 2024 | 1.447 |
| August 29, 2024 | 1.546 |
| August 28, 2024 | 1.446 |
| August 27, 2024 | 1.378 |
| August 26, 2024 | 1.309 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.0742
Minimum
May 29 2024
3.646
Maximum
Dec 01 2021
1.076
Average
0.5711
Median
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.096 |
| Theriva Biologics Inc | 0.0799 |
| Oragenics Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 31.25 |
| PEG Ratio | -0.001 |
| Price | 11.95 |
| Earnings Yield | -73.81% |
| Market Cap | 19.19M |
| PEGY Ratio | -0.001 |